Which is the better approach - to yank a dangerous drug, or severely restrict it?
In Europe, however, patients currently on rosiglitazone-containing drugs will have to find other options, now that the European Medicines Agency has suspended the marketing authorization for the treatments. As DJN reports, the EMA says patients taking rosiglitazone shouldn’t stop on their own, but should make an appointment with a physician to discuss their options.
Source: FDA Keeps GSK's Diabetes Drug Avandia on Market, Europeans Recommend its Removal - Health Blog - WSJ
As I mentioned over at my other website, this will probably cause more Avandia lawsuits to be brought here in the U.S.A.